Jim Simons
OLMA icon

Jim Simons’s Olema Pharmaceuticals OLMA Stock Holding History

Jim Simons’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,067
Closed -$627K – 3561
2025
Q4 		$627K Sell
25,067
-65,033
-72% -$1.16M ﹤0.01% 2486
2025
Q3 		$882K Buy
90,100
+31,300
+53% +$188K ﹤0.01% 2551
2025
Q2 		$250K Sell
58,800
-5,800
-9% -$25.9K ﹤0.01% 3093
2025
Q1 		$243K Sell
64,600
-92,700
-59% -$466K ﹤0.01% 3002
2024
Q4 		$917K Buy
157,300
+127,900
+435% +$1.28M ﹤0.01% 2544
2024
Q3 		$351K Sell
29,400
-23,800
-45% -$304K ﹤0.01% 2921
2024
Q2 		$576K Buy
+53,200
New +$577K ﹤0.01% 2627
2024
Q1 		– Sell
-173,611
Closed -$2.44M – 3964
2023
Q4 		$2.44M Sell
173,611
-136,889
-44% -$1.84M ﹤0.01% 1832
2023
Q3 		$3.83M Buy
310,500
+17,600
+6% +$179K 0.01% 1453
2023
Q2 		$2.65M Buy
292,900
+35,700
+14% +$216K ﹤0.01% 1821
2023
Q1 		$892K Sell
257,200
-9,000
-3% -$36.7K ﹤0.01% 2550
2022
Q4 		$652K Sell
266,200
-114,300
-30% -$333K ﹤0.01% 2787
2022
Q3 		$1.05M Buy
380,500
+94,366
+33% +$400K ﹤0.01% 2469
2022
Q2 		$1.17M Buy
286,134
+38,802
+16% +$123K ﹤0.01% 2608
2022
Q1 		$1.05M Buy
+247,332
New +$1.36M ﹤0.01% 2692
2021
Q4 		– Sell
-97,900
Closed -$2.7M – 4134
2021
Q3 		$2.7M Buy
+97,900
New +$2.64M ﹤0.01% 1870

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Jim Simons's OLMA Position: Q1 2026 in Review

Jim Simons sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 25,067 shares — an estimated $627K sold.

Jim Simons first reported a position in OLMA in Q3 2021 and held it in 16 quarters. The position peaked at $3.83M in Q3 2023. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Jim Simons reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jim Simons sold 25,067 Olema Pharmaceuticals shares in Q1 2026, an estimated $627K.
  • Jim Simons first reported a position in Olema Pharmaceuticals in Q3 2021 and held it in 16 quarters.
  • Jim Simons's Olema Pharmaceuticals position peaked at $3.83M in Q3 2023.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.